1.

Gemcitabine in brief versus prolonged low-dose infusion for advanced non-small cell lung cancer

Publication of results of a clinical trial. We confirmed that our original schedule of application of gemcitabine in low-dose (not more than 20% of the usual dose) in prolonged infusion leads to at least equal, and possibly better (for squamous carcinoma) results when compared to standard high-dose application in brief infusion

COBISS.SI-ID: 805243

2.

Oncology - a survey on methods of clinical trials

Chapter in a multi-author volume (20 pages)

COBISS.SI-ID: 757627

3.

Gemcitabine in brief infusion vs. low-dose gemcitabine in long infusion and cisplatin for patients with advanced NSCLC and poor performance status

Publication of a clinical trial. Treatment with low-dose gemcitabine in prolonged infusion and cisplatin was significantly superior to high-dose gemcitabine

COBISS.SI-ID: 968315

4.

Intermittent chemotherapy and targeted therapy for patients with lung cancer

Scientific basis for intermittent therapy, based on differences in cell kinetics

COBISS.SI-ID: 1013115

5.

Intermittent chemotherapy and erlotinib for patients with advanced lung adenocarcinoma

Report on results of a clinical trial

COBISS.SI-ID: 000000000